Vinay Prasad is back at the FDA, and in a position in which grappling with nuance — not always his strong suit — will be the ...

Specifically, the latest guidelines say that researchers should not use any stem cell-based embryo models to try to start a ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

He could appeal the decision to the director of the NIH, Dr. Jay Bhattacharya. It was a name Garber knew exceptionally well. For more than three decades, Garber had nurtured Bhattacharya’s career, ...

A small study finds that an off-the-shelf vaccine candidate by Elicio Therapeutics boosted immune response in pancreatic ...

Studies have shown that the provision of medication abortion via telehealth services is both safe and effective at the same ...

Today, we discuss lots of government maneuvering that impacts biopharma — starting, of course, with the FDA reinstating Vinay ...

Good morning. A lot happened at federal health agencies this weekend. Scroll down for everything we know about the shooting ...

Plus more pharma news from the Pharmalittle newsletter.

The most cumbersome administrative obstacles that new primary care practices face have little to do with federal regulation.

In every way, a study published this January in a major medical journal was a win for UnitedHealth Group. It showed that ...